Literature DB >> 11757760

Evaluation of renal biopsy samples of patients with diabetic nephropathy.

D Suzuki1, H Takano, M Toyoda, T Umezono, G Uehara, T Sakai, S Y Zhang, Y Mori, M Yagame, M Endoh, H Sakai.   

Abstract

OBJECTIVE: To evaluate the usefulness of renal biopsy in the overall management of patients with diabetes mellitus (DM), we examined the relationship between the clinical parameters and histopathological findings of renal biopsy samples.
METHODS: Renal biopsy specimens were obtained from 109 type 2 diabetic patients with proteinuria. Samples were divided into the following two groups: Diabetic Nephropathy (DN) group (n=80) had typical diabetic lesions without other renal diseases, complication group (n=29) had diabetic lesions with other renal diseases. Furthermore, DN group was subdivided into two subgroups: slow progressive group (SP group, n=32), the level of serum creatinine (s-Cr) was normal at the time of renal biopsy and three years after renal biopsy, and fast progressive group (FP group, n=14), the level of s-Cr was normal at the time of renal biopsy but more than doubled three years after renal biopsy.
RESULTS: The level of total protein was significantly lower and HbA1c significantly higher in the DN group than in the Complication group. However, other clinical parameters were not significantly different between the two groups. Urinary protein, systolic and diastolic blood pressure in FP group were significantly higher than in SP group. The percentage of sclerotic glomeruli, the severity of mesangial expansion, tubular injury and cell infiltration were significantly greater in FP than in SP group.
CONCLUSIONS: Our results indicated that a complete evaluation of renal pathology in DM could not be made by clinical parameters only, and that the progression of DN could be accurately predicted by histopathological evaluation. Therefore, this study emphasizes the importance of renal biopsy in the overall management of patients with DM and/or DN.

Entities:  

Mesh:

Year:  2001        PMID: 11757760     DOI: 10.2169/internalmedicine.40.1077

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  15 in total

1.  Clinicopathological analysis of biopsy-proven diabetic nephropathy based on the Japanese classification of diabetic nephropathy.

Authors:  Kengo Furuichi; Miho Shimizu; Yukio Yuzawa; Akinori Hara; Tadashi Toyama; Hiroshi Kitamura; Yoshiki Suzuki; Hiroshi Sato; Noriko Uesugi; Yoshifumi Ubara; Junichi Hohino; Satoshi Hisano; Yoshihiko Ueda; Shinichi Nishi; Hitoshi Yokoyama; Tomoya Nishino; Kentaro Kohagura; Daisuke Ogawa; Koki Mise; Yugo Shibagaki; Hirofumi Makino; Seiichi Matsuo; Takashi Wada
Journal:  Clin Exp Nephrol       Date:  2017-10-27       Impact factor: 2.801

2.  Evidence-based practice guideline for the treatment of CKD.

Authors: 
Journal:  Clin Exp Nephrol       Date:  2009-12       Impact factor: 2.801

3.  Diabetic retinopathy in predicting diabetic nephropathy in patients with type 2 diabetes and renal disease: a meta-analysis.

Authors:  F He; X Xia; X F Wu; X Q Yu; F X Huang
Journal:  Diabetologia       Date:  2012-12-12       Impact factor: 10.122

4.  Evaluation of renal biopsies in type 2 diabetic patients with kidney disease: a clinicopathological study of 216 cases.

Authors:  Li Zhuo; Wenwen Ren; Wenge Li; Guming Zou; Jianhua Lu
Journal:  Int Urol Nephrol       Date:  2012-04-01       Impact factor: 2.370

Review 5.  Is the present cut-point to define type 2 diabetes appropriate in Latin-Americans?

Authors:  Patricio López-Jaramillo; Carlos Velandia-Carrillo; Diego Gómez-Arbeláez; Martin Aldana-Campos
Journal:  World J Diabetes       Date:  2014-12-15

6.  Roux-en-Y gastric bypass reverses renal glomerular but not tubular abnormalities in excessively obese diabetics.

Authors:  Jabbar Saliba; Nader R Kasim; Robyn A Tamboli; James M Isbell; Pam Marks; Irene D Feurer; Alp Ikizler; Naji N Abumrad
Journal:  Surgery       Date:  2009-12-11       Impact factor: 3.982

7.  Prevalence of diabetic nephropathy complicating non-diabetic renal disease among Chinese patients with type 2 diabetes mellitus.

Authors:  Li Zhuo; Guming Zou; Wenge Li; Jianhua Lu; Wenwen Ren
Journal:  Eur J Med Res       Date:  2013-02-22       Impact factor: 2.175

8.  Identifying parameters to distinguish non-diabetic renal diseases from diabetic nephropathy in patients with type 2 diabetes mellitus: a meta-analysis.

Authors:  Shuang Liang; Xue-Guang Zhang; Guang-Yan Cai; Han-Yu Zhu; Jian-Hui Zhou; Jie Wu; Pu Chen; Shu-Peng Lin; Qiang Qiu; Xiang-Mei Chen
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

9.  Study design of DIACORE (DIAbetes COhoRtE) - a cohort study of patients with diabetes mellitus type 2.

Authors:  Lena Dörhöfer; Alexander Lammert; Vera Krane; Mathias Gorski; Bernhard Banas; Christoph Wanner; Bernhard K Krämer; Iris M Heid; Carsten A Böger
Journal:  BMC Med Genet       Date:  2013-02-14       Impact factor: 2.103

10.  Is the presence of retinopathy of practical value in defining cases of diabetic nephropathy in genetic association studies? The experience with the ACE insertion/deletion polymorphism in 53 studies comprising 17,791 subjects.

Authors:  Daniel P K Ng; Bee-Choo Tai; Xiu-Li Lim
Journal:  Diabetes       Date:  2008-06-03       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.